Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Andrew Dudum

CEO at Hims & Hers Health, Inc. (HIMS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $11.0M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 2,79292,523 held (−3%) $62.65 $175K -50.6%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 39,11155,947 held (−41%) $62.70 $2.5M -50.7%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 8,42347,524 held (−15%) $63.46 $535K -51.3%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 17,00192,523 held (−16%) $62.69 $1.1M -50.7%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 39,531161,326 held (−20%) $62.71 $2.5M -50.7%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 10,469150,857 held (−6%) $63.49 $665K -51.3%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 39,332111,525 held (−26%) $62.70 $2.5M -50.7%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 2,335109,190 held (−2%) $63.39 $148K -51.2%
Oct 20SEC HIMSHims & Hers Health, Inc. Sell Plan 16,66792,523 held (−15%) $62.70 $1.0M -50.7%
  • Sell

    CEO Andrew Dudum sold $175K of HIMS at $62.65 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Andrew Dudum sold $2.5M of HIMS at $62.70 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Andrew Dudum sold $535K of HIMS at $63.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Andrew Dudum sold $1.1M of HIMS at $62.69 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Andrew Dudum sold $2.5M of HIMS at $62.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO Andrew Dudum sold $665K of HIMS at $63.49 — pre-scheduled 10b5-1 plan sale.